Aurélie Cravoisy

3.4k total citations
22 papers, 2.2k citations indexed

About

Aurélie Cravoisy is a scholar working on Epidemiology, Critical Care and Intensive Care Medicine and Immunology. According to data from OpenAlex, Aurélie Cravoisy has authored 22 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 7 papers in Critical Care and Intensive Care Medicine and 7 papers in Immunology. Recurrent topics in Aurélie Cravoisy's work include Sepsis Diagnosis and Treatment (10 papers), Inflammation biomarkers and pathways (6 papers) and Nosocomial Infections in ICU (4 papers). Aurélie Cravoisy is often cited by papers focused on Sepsis Diagnosis and Treatment (10 papers), Inflammation biomarkers and pathways (6 papers) and Nosocomial Infections in ICU (4 papers). Aurélie Cravoisy collaborates with scholars based in France and United States. Aurélie Cravoisy's co-authors include Sébastien Gibot, Pierre‐Édouard Bollaert, G Fauré, Marie C. Béné, Bruno Lévy, Damien Barraud, Marie‐Nathalie Kolopp‐Sarda, Lionel Nace, Bruno Lévy and Patricia Franck and has published in prestigious journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Aurélie Cravoisy

20 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aurélie Cravoisy France 13 1.1k 967 468 359 328 22 2.2k
Benjamin Tang Australia 22 1.4k 1.4× 620 0.6× 442 0.9× 441 1.2× 371 1.1× 53 3.3k
Bruno Lévy France 20 858 0.8× 1.3k 1.3× 399 0.9× 346 1.0× 376 1.1× 37 2.3k
Fabián Jaimes Colombia 22 1.0k 1.0× 291 0.3× 351 0.8× 293 0.8× 269 0.8× 151 2.1k
Lonneke A. van Vught Netherlands 28 1.4k 1.3× 563 0.6× 631 1.3× 141 0.4× 473 1.4× 55 2.7k
Peter M. C. Klein Klouwenberg Netherlands 24 1.4k 1.3× 450 0.5× 874 1.9× 150 0.4× 307 0.9× 34 2.5k
Aníbal Basile-Filho Brazil 23 510 0.5× 553 0.6× 299 0.6× 133 0.4× 355 1.1× 133 2.1k
Fabrice Zéni France 33 1.4k 1.3× 568 0.6× 645 1.4× 300 0.8× 639 1.9× 76 3.3k
Debra Foster United States 14 985 0.9× 510 0.5× 583 1.2× 116 0.3× 417 1.3× 33 1.7k
Damien Barraud France 18 592 0.6× 384 0.4× 269 0.6× 146 0.4× 167 0.5× 28 1.4k
Jean‐Marc Tadié France 27 638 0.6× 776 0.8× 285 0.6× 98 0.3× 478 1.5× 76 2.3k

Countries citing papers authored by Aurélie Cravoisy

Since Specialization
Citations

This map shows the geographic impact of Aurélie Cravoisy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aurélie Cravoisy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aurélie Cravoisy more than expected).

Fields of papers citing papers by Aurélie Cravoisy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aurélie Cravoisy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aurélie Cravoisy. The network helps show where Aurélie Cravoisy may publish in the future.

Co-authorship network of co-authors of Aurélie Cravoisy

This figure shows the co-authorship network connecting the top 25 collaborators of Aurélie Cravoisy. A scholar is included among the top collaborators of Aurélie Cravoisy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aurélie Cravoisy. Aurélie Cravoisy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schaefer, Marion, et al.. (2025). Esophageal Achalasia: An Unusual Cause of Respiratory Distress. Case Reports in Critical Care. 2025(1). 1829559–1829559.
4.
Cravoisy, Aurélie, et al.. (2021). Lactic acidosis and hypoglycemia as markers of disease progression of multiple myeloma: A case report. SHILAP Revista de lepidopterología. 2(3). 539–544. 3 indexed citations
5.
Grard, Gilda, Pierre‐Édouard Bollaert, Guillaume André Durand, et al.. (2020). Viscerotropic disease and acute uveitis following yellow fever vaccination: a case report. BMC Infectious Diseases. 20(1). 116–116. 10 indexed citations
6.
Cravoisy, Aurélie, Jérémie Lemarie, Marie Conrad, et al.. (2019). Automated measurement of neutrophil CD64 expression for diagnosing sepsis in critically ill patients. Minerva Anestesiologica. 85(9). 943–950. 11 indexed citations
7.
Gaci, Rostane, Jérémie Lemarie, Marie Conrad, et al.. (2018). Early hypertension after vasopressor weaning during septic shock: associated factors and prognostic significance. Minerva Anestesiologica. 84(2). 196–203.
8.
Cravoisy, Aurélie, Damien Barraud, Marie Conrad, et al.. (2013). Factors influencing the implementation of antibiotic de-escalation and impact of this strategy in critically ill patients. Critical Care. 17(4). R140–R140. 66 indexed citations
9.
Gibot, Sébastien, Marie C. Béné, Robin Noël, et al.. (2012). Combination Biomarkers to Diagnose Sepsis in the Critically Ill Patient. American Journal of Respiratory and Critical Care Medicine. 186(1). 65–71. 213 indexed citations
10.
Quenot, Jean‐Pierre, Christophe Milési, Aurélie Cravoisy, et al.. (2011). Transport intrahospitalier des patients à risque vital (nouveau-né exclu). Annales Françaises d Anesthésie et de Réanimation. 30(12). 952–956. 1 indexed citations
11.
Barraud, Damien, Aurélie Cravoisy, Lionel Nace, et al.. (2010). Probiotics in the critically ill patient: a double blind, randomized, placebo-controlled trial. Intensive Care Medicine. 36(9). 1540–1547. 111 indexed citations
12.
Jay, Nicolas, Damien Barraud, Aurélie Cravoisy, et al.. (2008). Metformin-associated lactic acidosis in an intensive care unit. Critical Care. 12(6). R149–R149. 114 indexed citations
13.
Gibot, Sébastien, Frédéric Massin, Aurélie Cravoisy, et al.. (2007). High-mobility group box 1 protein plasma concentrations during septic shock. Intensive Care Medicine. 33(8). 1347–1353. 125 indexed citations
14.
Gibot, Sébastien, Aurélie Cravoisy, Damien Barraud, et al.. (2007). Combined measurement of procalcitonin and soluble TREM-1 in the diagnosis of nosocomial sepsis. Scandinavian Journal of Infectious Diseases. 39(6-7). 604–608. 35 indexed citations
15.
Gibot, Sébastien, Frédéric Massin, Aurélie Cravoisy, et al.. (2007). Growth arrest-specific protein 6 plasma concentrations during septic shock. Critical Care. 11(1). R8–R8. 56 indexed citations
16.
Cravoisy, Aurélie, et al.. (2007). Perception par les patients de leur séjour en réanimation. La Presse Médicale. 36(2). 211–216. 10 indexed citations
17.
Gibot, Sébastien, Aurélie Cravoisy, Marie‐Nathalie Kolopp‐Sarda, et al.. (2005). Time-course of sTREM (soluble triggering receptor expressed on myeloid cells)-1, procalcitonin, and C-reactive protein plasma concentrations during sepsis. Critical Care Medicine. 33(4). 792–796. 191 indexed citations
18.
Lévy, Bruno, Sébastien Gibot, Patricia Franck, Aurélie Cravoisy, & Pierre‐Édouard Bollaert. (2005). Relation between muscle Na+K+ ATPase activity and raised lactate concentrations in septic shock: a prospective study. The Lancet. 365(9462). 871–875. 348 indexed citations
19.
Gibot, Sébastien & Aurélie Cravoisy. (2004). Soluble Form of the Triggering Receptor Expressed on Myeloid Cells-1 as a Marker of Microbial Infection. Clinical Medicine & Research. 2(3). 181–187. 110 indexed citations
20.
Gibot, Sébastien, Aurélie Cravoisy, Bruno Lévy, et al.. (2004). Soluble Triggering Receptor Expressed on Myeloid Cells and the Diagnosis of Pneumonia. New England Journal of Medicine. 350(5). 451–458. 466 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026